Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

Summary

This demonstration project will assess the acceptability and feasibility of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of a comprehensive HIV prevention package in community-based clinics in West Africa.

An interventional, open label, multidisciplinary and multicentre cohort study will be performed in Burkina Faso, Côte d'Ivoire, Mali, and Togo.

All MSM enrolled will benefit from a comprehensive HIV prevention package including quarterly clinical examinations, screening and treatment of STIs, screening of HIV, PrEP (daily or on-demand, according the participant's choice), immunisation against hepatitis B, individualised peer-led support (for adherence and prevention), group discussions, condoms, and lubricants.

Conditions

• HIV/AIDS

Interventions

DRUG

HIV prevention package including PrEP

All MSM enrolled will benefit from a comprehensive HIV prevention package including quarterly clinical examinations, screening and treatment of STIs, screening of HIV, PrEP (TDF 300 mg + FTC 200 mg), daily or on-demand, according the participant's choice, immunisation against hepatitis B, individualised peer-led support (for adherence and prevention), group discussions, condoms, and lubricants.

Sponsors & Collaborators

• Expertise France

  collaborator OTHER

• Université Montpellier

  collaborator OTHER

• SESSTIM (IRD, Inserm, Université Aix-Marseille)

  collaborator UNKNOWN

• Coalition Internationale Sida

  collaborator OTHER

• Institut de Médecine Tropicale, Anvers, Belgique

  collaborator UNKNOWN

• ARCAD-SIDA MALI

  collaborator OTHER

• Association African Solidarité

  collaborator OTHER

• Centre de Recherche Internationale pour la Santé, Université de Ouagadougou

  collaborator UNKNOWN

• Espace Confiance, Côte d'Ivoire

  collaborator OTHER

• Espoir Vie-Togo - ONG

  collaborator OTHER

• Laboratoire BIOLIM, Université de Lomé

  collaborator UNKNOWN

• ANRS, Emerging Infectious Diseases

  lead OTHER_GOV

Study Design

Allocation

NA

Purpose

PREVENTION

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

MALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2017-11-20

Primary Completion

2020-12-23

Completion

2021-06-30

Countries

• Burkina Faso
• Côte d’Ivoire
• Mali
• Togo

Study Locations